Key facts
- This page summarizes Michael J. Higgins's Form 4 filing for Pulmatrix, Inc. (PULM).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 30 Jan 2023, 15:05.
Michael J. Higgins - 26 Jan 2023 Form 4 Insider Report for Pulmatrix, Inc. (PULM)
- Reporting relationship
- Director
- Issuer ticker
- PULM
- Reported as of
- 26 Jan 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 30 Jan 2023, 15:05:47 UTC
- Prior SEC filing
- 18 Jul 2022
- Next SEC filing
- 07 Jun 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Michael Higgins
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Michael J. Higgins filed Form 4 for Pulmatrix, Inc. (PULM) on 30 Jan 2023.
Change
- Previous filing in this sequence was filed on 18 Jul 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PULM
transaction
Derivative
Stock Option (Right to Buy)
Award
- Transaction value
- $0
- Shares
- +2,436
- Change %
- Price
- $0.000000
- Shares after
- 2,436
- Date
- 26 Jan 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,436
- Exercise price
- $3.99
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
The shares underlying this stock option will vest and become exercisable in forty-eight (48) equal monthly installments with the first tranche vesting on January 26, 2023, provided that the reporting person is providing services to the Issuer on the applicable vesting date and subject to the terms and conditions of the Pulmatrix, Inc. Amended and Restated 2013 Employee, Director and Consultant Equity Incentive Plan.